Trading Statement

Tate & Lyle PLC
                  

29 March 2005 - Tate & Lyle PLC

Trading Update prior to Closed Period

Before entering its closed period for the year ending 31 March 2005 and prior to
meeting with stockbrokers' analysts, Tate & Lyle issues the following routine
trading update. The preliminary announcement of results for the year ending 31
March 2005 will be made on 2 June 2005.

Since the update on 25 January 2005 Tate & Lyle's overall trading performance
has continued to be good and in line with our expectations.

Demand for our high intensity sweetener SPLENDA® Sucralose remains very strong
with current production capacity fully utilised. Work on the plant expansions in
McIntosh, Alabama, and the construction of the new plant in Singapore remains on
track. There have been recent announcements concerning the launch of diet
carbonated soft drinks which will include SPLENDA® Sucralose.

Food and Industrial Ingredients, Americas has performed well, again benefiting
from growth in value added food ingredients.

The construction of the Bio-3G plant in Loudon, Tennessee, is progressing
satisfactorily.

Our sugar operations in Canada, Vietnam and Mexico continue to perform in line
with our expectations.

The good performance from SPLENDA® Sucralose has offset both lower sweetener
margins in Food and Industrial Ingredients, Europe (as reported in our trading
update on 25 January 2005), and the impact of higher cost export licences in
Sugars, Europe.


For more information contact Tate & Lyle PLC:
Mark Robinson, Head of Investor Relations
Tel: [phone] or Mobile: [phone]

Chris Fox, Director of Corporate Relations (Press)
Tel: [phone] or Mobile: [phone]


About Tate & Lyle:

Tate & Lyle is a world leading manufacturer of renewable food and industrial
ingredients.

It uses innovative technology to transform corn, wheat and sugar into
value-added ingredients for customers in the food, beverage, pharmaceutical,
cosmetic, paper, packaging and building industries. The Company is a leader in
cereal sweeteners and starches, sugar refining, value added food and industrial
ingredients, and citric acid. Tate & Lyle is the world number-one in industrial
starches and is the sole manufacturer of SPLENDA® Sucralose.

Headquartered in London, Tate & Lyle is listed on the London Stock Exchange
under the symbol TATE.L. In the US its ADRs trade under TATYY. The Company
operates more than 60 production facilities in 28 countries, throughout Europe,
the Americas and South East Asia. It employs 6,700 people in its subsidiaries
with a further 4,800 employed in joint ventures. Sales in the year to 31 March
2004 totalled £3.1 billion. Additional information can be found on
www.tateandlyle.com.

SPLENDA® is a trademark of McNeil Nutritionals, LLC